Ekso Bionics Holdings, Inc. Quarterly report pursuant to sections 13 or 15(d)

Quarterly report pursuant to sections 13 or 15(d)

Accrued Expenses

Accrued Expenses	9 Months Ended
Dec. 31, 2013
DisclosureAccruedExpensesAbstract
Accrued expenses	NOTE 3 – ACCRUED EXPENSES Accrued expenses at December 31, 2013 and March 31, 2013 consisted of amounts owed to the Company’s outside independent auditors for services rendered for periods reported on in these financial statements.

Accrued Expenses

9 Months Ended

Dec. 31, 2013

NOTE 3 – ACCRUED EXPENSES

Accrued expenses at December 31, 2013 and March 31, 2013 consisted of amounts owed to the Company’s outside independent auditors for services rendered for periods reported on in these financial statements.